[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359459-105":59,"doc-detail-359459-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","artificial-intelligence-in-breast-cancer-applications-and-advancements","Artificial intelligence in breast cancer - applications and advancements","","Breast cancer is the most common malignant tumor among women globally, creating a major public health burden because traditional workflows in diagnosis and treatment rely on subjective interpretation and struggle to integrate multidimensional data. Deep learning and machine learning have become transformative tools. In clinical practice, AI supports imaging screening, digital pathology for tumor typing and gene mutation prediction, decision-support systems for guideline compliance, and drug R&D via target identification and virtual screening.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/artificial-intelligence-in-breast-cancer-applications-and-advancements/359459/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/artificial-intelligence-in-breast-cancer-applications-and-advancements/359459.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does AI address limitations in traditional breast cancer diagnosis and treatment?","Question",{"text":112,"@type":113},"AI helps reduce subjectivity and improves integration of large, multidimensional clinical datasets. Deep learning and machine learning support more consistent diagnostic and decision-making processes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the major clinical applications of AI in breast cancer care?",{"text":117,"@type":113},"The review highlights AI use in imaging screening, digital pathology for tumor typing and gene mutation prediction, treatment decision-support for guideline compliance, and drug research and development for target identification and virtual screening.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges remain for implementing AI in breast cancer?",{"text":121,"@type":113},"Key challenges include data standardization problems, limited clinical accessibility, and unclear ethical-legal responsibilities. The review points to national data standards, multi-center training, hierarchical physician training, and explainable AI as targeted solutions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359459,1790219704,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Cancer Biol Med 2026. doi: 10.20892/j.issn.2095-3941.2025.0704  \nREVIEW  \nArtificial intelligence in breast cancer: applications and advancements  \nJianbin Li 1,2, Zefei Jiang 1  \n1Senior Department of Oncology, Chinese PLA General Hospital, Beijing 100071, China; 2 National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China  \n\n| ABSTRACT | Breast cancer is the most common malignant tumor among women globally and poses a major public health challenge due to limitations in traditional diagnostic and treatment processes, such as subjective interpretation biases and inefficient multidimensional data integration. Artificial intelligence (AI), particularly deep learning and machine learning technologies, has emerged as a transformative tool in addressing these issues. Clinically, AI has been widely applied in imaging screening to improve detection rates and reduce reading time, digital pathology for precise tumor typing and gene mutation prediction, treatment decisionsupport systems to enhance guideline compliance, and drug research and development to accelerate target identification and virtual screening. Despite these achievements, AI implementation faces challenges, such as data standardization issues, limited model |\n| --- | --- |\n| KEYWORDS | generalization, low clinical accessibility, and unclear ethical-legal responsibilities, which require targeted solutions that include national data standards, multi-center training, hierarchical physician training, and explainable AI. Future directions involve multimodal data integration, human-AI collaborative multidisciplinary team models, and extension to full-cycle health management from prevention-to-rehabilitation. This review provides a systematic overview ofthe role ofAI in breast cancer care, offering insights for clinical practice and scientific research innovation, and supporting the transition toward personalized and intelligent medicine in oncology.\u003Cbr>Artificial intelligence; breast cancer; application; challenge |\n\nIntroduction  \nThe 2025 global cancer statistics show that breast cancer is the most common malignant tumor among women with greater than 2.3 million new cases and approximately 680,000 deaths each year1. Despite advances in diagnosis and treatment, breast cancer continues to pose a major public health challenge. Traditional diagnostic and treatment processes still depend heavily on human judgment. Radiologists interpret breast imaging based on personal experience, while pathologists face variability in tissue typing due to subjective factors. Treatment decisions also require the integration of large amounts of multi-dimensional clinical data. These complexities often result in inconsistent  \ndiagnostic accuracy and treatment outcomes across medical centers2.  \nArtificial intelligence (AI) offers a new way to address these issues. Advances in deep learning (DL) and machine learning (ML) have enabled AI to assist in nearly every stage of breast cancer management. By 2025, more than 50 AI-based breast cancer systems have received certification worldwide. These technologies now support imaging screening, pathologic interpretation, and clinical decision-making. Some AI systems have shown performance comparable to that of experienced clinicians in validation studies. This article comprehensively reviews AI advances in breast cancer management from three aspects, providing a basis for clinical practice and scientific research innovation: technical principles; clinical applications; and challenges and prospects.  \nCorrespondence to: Zefei Jiang  \n[E-mail: jiangzefei@csco.org.cn](E-mail: jiangzefei@csco.org.cn)  \nORCID ID: [https://orcid.org/0000-0002-4295-0173](https://orcid.org/0000-0002-4295-0173)[ ](https://orcid.org/0000-0002-4295-0173)[Received November 12](Received November 12), 2025; accepted February 5, 2026. Available [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2026 The Authors. Creative Commons Attri","cbCaigeIYpGPPpUv","https://ap.wps.com/l/cbCaigeIYpGPPpUv","pdf",306489,11,"English","# Introduction\n## Iteration of medical models and evolution of AI technologies\n## Empirical medicine era (before 2010)\n## Traditional machine learning era (2010–2015)\n## Deep learning era (2016–2020)","[{\"question\":\"How does AI address limitations in traditional breast cancer diagnosis and treatment?\",\"answer\":\"AI helps reduce subjectivity and improves integration of large, multidimensional clinical datasets. Deep learning and machine learning support more consistent diagnostic and decision-making processes.\"},{\"question\":\"What are the major clinical applications of AI in breast cancer care?\",\"answer\":\"The review highlights AI use in imaging screening, digital pathology for tumor typing and gene mutation prediction, treatment decision-support for guideline compliance, and drug research and development for target identification and virtual screening.\"},{\"question\":\"What challenges remain for implementing AI in breast cancer?\",\"answer\":\"Key challenges include data standardization problems, limited clinical accessibility, and unclear ethical-legal responsibilities. The review points to national data standards, multi-center training, hierarchical physician training, and explainable AI as targeted solutions.\"}]","Artificial intelligence in breast cancer - applications and advancements | PDF",1790136939,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8af42f650f87ff620acfb3a3090d1d5a.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16c9699082ee3ba94bee02b7905a9215.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41d87954508be88e9d6fbe443d26ab9e.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cba090929ec9ac01650f9cae84ae48b6.webp",980,1283]